Denmark - August 6, 2025
Novo Nordisk lowers sales and operating profit outlook for 2025 and makes organizational changes
Novo Nordisk has announced sales and operating profit growth at constant exchange rates (CER) for the first six months of 2025 and updated full-year sales and operating profit outlook at CER.
Collaboration - July 16, 2025
EUR 80 million investment in new Nordic quantum initiative
EIFO, the export and investment fund of Denmark, and the Novo Nordisk Foundation are investing in the establishment of QuNorth, with the purpose to advance the region’s technological development.
Denmark - April 23, 2025
New Danish national gateway to health data
A DKK 200 million grant from the Novo Nordisk Foundation will enable a new national “one point of entry” gateway to health data to be established in Denmark.
Collaboration - February 26, 2025
Medicon Valley Alliance joins the Danish AMR Alliance
“MVA is happy to join the Danish AMR Alliance, contribute to the the crucial fight against antimicrobial resistance and help knowledge share, raise awareness and bridge current and future Swedish and Danish initiatives aiming to to make a difference for global health. As a follow-up to our 2024 Annual Summit session “AMR – challenges and initiatives […]
Biotech article - January 21, 2025
First Danish patients treated with gene therapy for haemophilia B
CSL Behring Denmark has announced that the first Danish patients with haemophilia B were treated with the gene therapy HEMGENIX (etranacogene dezaparvovec).
Denmark - December 18, 2024
Novo Nordisk invests DKK 8.5 billion in new production facility
Novo Nordisk has announced plans to establish a completely new production facility in Odense, Denmark.
